MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹11,907 Cr | ₹9,919 Cr | ₹8,012 Cr | ₹6,735 Cr | ₹5,304 Cr |
What is the latest Profit & Loss Account Balance ratio of MANKIND PHARMA ?
Year | Profit & Loss Account Balance |
---|---|
Mar2025 | ₹11,907 Cr |
Mar2024 | ₹9,919 Cr |
Mar2023 | ₹8,012 Cr |
Mar2022 | ₹6,735 Cr |
Mar2021 | ₹5,304 Cr |
How is Profit & Loss Account Balance of MANKIND PHARMA Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2025 | ₹11,907 Cr | 20.05 | |
Mar2024 | ₹9,919 Cr | 23.80 | |
Mar2023 | ₹8,012 Cr | 18.96 | |
Mar2022 | ₹6,735 Cr | 26.99 | |
Mar2021 | ₹5,304 Cr | - |
Compare Profit & Loss Account Balance of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹108,902.8 Cr | 2.3% | 5.9% | 4.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,626.0 Cr | 2% | 1.4% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,996.0 Cr | 1.3% | 0.3% | 10.4% | Stock Analytics | |
CIPLA | ₹127,494.0 Cr | 0.3% | 1.9% | -6.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,718.0 Cr | 0% | -2.3% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,374.0 Cr | 0.5% | 6.2% | -1.4% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 2.3% |
5.9% |
4.6% |
SENSEX | 1.8% |
2.1% |
0.2% |
You may also like the below Video Courses